Try our beta test site
1 study found for:    01508910
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Conditions: Chronic Myocardial Ischemia;   Refractory Angina Pectoris;   Advanced Coronary Heart Disease
Interventions: Biological: Auto-CD34+ cells;   Biological: Placebo: Diluent used to suspend Auto-CD34+ cells;   Other: Standard of care

Study has passed its completion date and status has not been verified in more than two years.